- Home
- UGI vs CORT Comparison
UGI vs CORT Comparison
Compare UGI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGI
- CORT
- Stock Information
- Founded
- UGI 1940
- CORT 1998
- Country
- UGI United States
- CORT United States
- Employees
- UGI N/A
- CORT N/A
- Industry
- UGI Natural Gas Distribution
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- UGI Utilities
- CORT Health Care
- Exchange
- UGI Nasdaq
- CORT Nasdaq
- Market Cap
- UGI 6.9B
- CORT 7.1B
- IPO Year
- UGI N/A
- CORT N/A
- Fundamental
- Price
- UGI $35.15
- CORT $74.21
- Analyst Decision
- UGI Buy
- CORT Strong Buy
- Analyst Count
- UGI 3
- CORT 4
- Target Price
- UGI $31.33
- CORT $142.00
- AVG Volume (30 Days)
- UGI 2.1M
- CORT 1.4M
- Earning Date
- UGI 05-07-2025
- CORT 05-05-2025
- Dividend Yield
- UGI 4.25%
- CORT N/A
- EPS Growth
- UGI N/A
- CORT 8.36
- EPS
- UGI 2.46
- CORT 1.14
- Revenue
- UGI $7,318,000,000.00
- CORT $685,446,000.00
- Revenue This Year
- UGI $6.20
- CORT $35.85
- Revenue Next Year
- UGI $8.02
- CORT $35.22
- P/E Ratio
- UGI $14.32
- CORT $64.25
- Revenue Growth
- UGI N/A
- CORT 30.93
- 52 Week Low
- UGI $22.01
- CORT $25.35
- 52 Week High
- UGI $34.49
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- UGI 67.64
- CORT 56.46
- Support Level
- UGI $33.97
- CORT $68.86
- Resistance Level
- UGI $35.37
- CORT $73.36
- Average True Range (ATR)
- UGI 0.69
- CORT 3.16
- MACD
- UGI 0.17
- CORT 0.06
- Stochastic Oscillator
- UGI 92.34
- CORT 85.76
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.